Esperion to Report Third Quarter 2022 Financial Results November 1, 2022
ANN ARBOR, Mich., Oct. 17, 2022 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced it will report third quarter 2022 financial results before the open of the U.S. financial markets on Tuesday, November 1st, 2022.
Following the release, company management will host a webcast at 8:00 a.m. ET to discuss the Company’s financial results and business progress. Please click to pre-register to participate in the conference call and obtain your dial in number and PIN.
Already registered? Access with your PIN .
A live audio webcast can be accessed on the investors and media section of the Esperion . Access to the webcast replay will be available approximately two hours after completion of the call and will be archived on the Company's website for approximately 90 days.
Esperion Therapeutics
Esperion works hard to make our medicines easy to get, easy to take and easy to have. We discover, develop, and commercialize innovative medicines and combinations to lower cholesterol, especially for patients whose needs aren’t being met by the status quo. Our entrepreneurial team of industry leaders is inclusive, passionate, and resourceful. We are singularly focused on managing cholesterol so you can improve your health easily. For more information, please visit and follow us on Twitter at .
Contact:
Corporate Communications
